Summary
The diagnostic significance of serum immunoreactive pancreatic phospholipase A2 (PLA2) was studied in 119 patients with pancreatic disease, 200 with various non-pancreatic disease, and 203 healthy controls using radioimmunoassay (RIA) specific to human pancreatic PLA2. This newly developed RIA using monoclonal antibody was satisfactorily sensitive and reliable. Serum PLA2 was elevated in all six patients with acute pancreatitis. Frequency of abnormal serum PLA2 levels was 60% in chronic pancreatitis (n=52) and 67% in pancreatic cancer (n=61). Serum PLA2 levels were low in chronic pancreatitis with severe exocrine insufficiency and advanced pancreatic cancer. In chronic pancreatitis, patients with low serum PLA2 level showed lower enzyme output in secretin test than patients with normal or high serum PLA2 level. Frequency of abnormal PLA2 levels was 27% in non-pancreatic disease and, in particular, patients with renal failure showed high PLA2 levels. Sensitivity (62%) and efficiency (69%) of serum PLA2 assay in pancreatic disease were superior to those of amylase. In conclusion, serum PLA2 determination using RIA was useful for the diagnosis of acute pancreatitis by high serum PLA2 levels and the diagnosis of severe exocrine pancreatic insufficiency by low serum PLA2 levels.
Similar content being viewed by others
References
Schmidt H, Creutzfeldt W: The possible role of phospholipase A in the pathogencsis of acute pancreatitis. Scand J Gastroenterol 1969;4:39–48
Schroder T, Kivilaakso E, Kinnuncn PKJ, et al: Serum phospholipase A2 in human acute pancreatitis. Scand J Gastroenterol 1980; 15:633–636
Nevalainen TJ, Aho HJ: Phospholipase A2 in acute pancreatitis. In: Berger HG. Bucher M, eds. Acute pancreatitis. Springer-Verlag, Berlin. 1987;71–78
Nevalainen TJ: Phospholipase A2 in acute pancreatitis. Scand J Gastrocnterol 1988;23:897–904
Hashihira S, Nishii T, Takeda Y, et al: Serum phospholipase A in patients with acute pancreatitis. Jpn Arch Intern Med 1977;24:243–249
Nevalaincn TJ, Eskola JU, Aho AJ, et al: Immunoreactivc phospholipase A2 in serum in acute pancreatitis and pancreatic cancer. Clin Chcm 1985;31:1116–1120
Matsuda Y, Ogawa M, Nishijima K, et al: Usefulness of determination of serum immunoreactive pancreatic phospholipase A2 content for early identification of severe acute pancreatitis. Hepato-gastroenterol 1986;33:214–216
Zieve L, Vogel MC: Measurement of lecithinasc A in serum and other body fluid. J Lab Clin Med 1961;57:586–599
Doizaki WM, Zieve L: Turbidimetric serum phospholipase A activity in acute pancreatitis. J Lab Clin Med 1966;67:108–115
Nishijima J, Okamoto M, Ogawa M, et al: Purification and characterization of human pancreatic phospholipase A2 and development of a radioimmunoassay. J Biochem 1983;94:137–147
Sternby B, Akerstrom B: Immunoreactive pancreatic colipase, lipase and phospholipase A2 in human plasma and urine from healthy individuals. Biochim Biophys Acta 1984;789:164–169
Ueda A, Yamaguchi A, Misaki A, et al: Radioimmunoassay of human pancreatic phospholipase A2. Jpn J Clin Pathol 1988;36(suppl):279 (in Japanese)
Ogawa M, Matsuda Y, Uda K, et al: Clinical evaluation of determination of serum pancreatic phospholipase A2 with monoclonal antibody. Gcndai Iryo 1988;20:3013–3017 (in Japanese)
Hermanek P, Sobin LH: TNM classification of malignant tumours. 4th ed. Springer-Verlag, Berlin. 1987
Caraway WT: A stable starch substrate for the determination of amylase in serum and other body fluids. Am J Clin Pathol 1959;32:97–99
Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980;47:1–9
Siegel S: Non-parametric statistics for the behavioral sciences. McGraw-Hill Co, New York. 1956
Shakir KMM: Phospholipase A2 activity of post-heparin plasma: A rapid and sensitive assay and partial characterization. Anal Biochem 1981;114:64–70
Katsumata M, Gupta C, Goldman AS: A rapid assay for activity of phospholipase A2 using radioactive substrate. Anal Biochem 1986;154:676–681
Heddrickson HS, Pauk PN: Continuous fluorometirc assay of phospholipase A2 with pyrene-labeled as a substrate. Anal Bioehcm 1981;116:553–558
Thurcn T, Virtanen JA, Lalla M, et al: Fluorometric assay for phospholipase A2 in serum. Clin Chem 1985;31:714–717
Hoffmann GE, Schmidt D, Bastian B, et al: Photometric determination of phospholipase A. J Clin Chem Clin Biochem 1986;24:871–875
Eskola JU, Nevalainen TJ, Lovgren TNE: Time-resolvcd fluoroimmunoassay of human pancreatic phospholipase A2. Clin Chem 1983;29:1777–1780
Kameya A, Hayakawa T, Noda A,et al: Differential determination of scrum isoamylase using an amylase inhibitor and its clinical application. Am J Gastroentcrol 1985;80:54–59
Hayakawa T, Noda A, Kondo T, et al: Diagnostic usefulness of serum lipase activity measured by enzyme immunoassay in pancreatic diseases. Jpn J Gastrocnterol 1985;82:2809–2815 (in Japanese)
Ogawa Y, Hayakawa T, Kondo T, et al: Diagnostic value of serum immunoreactive trypsin assay in pancreatic diseases using enzyme immunoassay. Jpn J Gastroenterol 1987;84:74–83 (in Japanese)
Masoero G, Andriulli A, Bianco A, et al: Diagnostic accuracy of serum cationic trypsinogen estimation of pancreatic diseases. Dig Dis Sci 1982;27:1089–1094
Schmidt D, Hoffmann GE: Activity of phospholipase A compared in scrum of patients with pancreatic and nonpancreatic diseases. Clin Chem 1987;33:594–596
Hamano H, Hayakawa T, Kondo T: Serum immunoreactive elastase in diagnosis of pancreatic disease. A sensitive marker for pancreatic cancer. Dig Dis Sci 1987;32:50–56
Matsuda Y, Ogawa M, Shibata T, et al: Distribution of immunoreactivc pancreatic phospholipase A2 (IPPL-2) in various tissues. Res Commun Pathol Pharmacol 1987;58:281–284
Author information
Authors and Affiliations
Additional information
This work was supported in part by a research grant for intractable pancreatic disease and a pancreatic cancer grant from the Ministry of Health and welfare of Japan.
Rights and permissions
About this article
Cite this article
Kitagawa, M., Hayakawa, T., Kondo, T. et al. The diagnostic value of serum pancreatic phospholipase A2 (PLA2) in pancreatic diseases. Gastroenterol Jpn 26, 62–68 (1991). https://doi.org/10.1007/BF02779511
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02779511